Newsletter

The monthly research briefing

A monthly note on what the peptide literature actually said that month — written the same way as the rest of this library, which means the disappointing results are in it too.

Newsletter

The monthly research briefing

One email a month on what was published about the peptides covered here — including the null and negative results — with each study's design, size and limitations stated. No offers, no prices, no products.

Your address is stored to send this one newsletter and nothing else. It is never sold, never rented, and never passed to RegenPep or to any manufacturer.

What is in it

What was actually published

New trials, preprints and reviews touching the compounds covered in the library — with the study type, how many subjects, and over what period.

The results that went nowhere

Null and negative findings are reported alongside positive ones. A month where nothing moved is reported as a month where nothing moved.

What the study cannot tell you

Every summary states its limitations: animal model, small sample, short duration, industry funding. Named, not buried.

Who paid for it

The researcher and the financial sponsor are identified on every study, with a citation you can follow to the source.

What is not in it

No offers, no prices, no discount codes, no stock notifications and no dosing. This site does not take payment and the briefing does not sell anything. Every issue carries a one-click unsubscribe.